Ironwood Pharmaceuticals IRWD Change in Lease Liabilities
Change in Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Ironwood Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.
The official record: Ironwood Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ironwood Pharmaceuticals's change in lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ironwood Pharmaceuticals's change in lease liabilities?
- Ironwood Pharmaceuticals (IRWD) reported change in lease liabilities of -$621K in Q1 2026.
- How has Ironwood Pharmaceuticals's change in lease liabilities changed year-over-year?
- Ironwood Pharmaceuticals's change in lease liabilities decreased by 8.6% year-over-year, from -$572K to -$621K.
- What is the long-term trend for Ironwood Pharmaceuticals's change in lease liabilities?
- Over 4 years (2021 to 2025), Ironwood Pharmaceuticals's change in lease liabilities has grown at a 6.6% compound annual growth rate (CAGR), from -$1.84M to -$2.37M.
- What does change in lease liabilities mean?
- Cash payments for operating leases reducing the lease liability, partially offset by new lease commencements.